"At Premier Vein & Vascular Center, our team of specialists treat a wide range of vascular conditions. Our treatment goes beyond reducing the appearance of veins. We also relieve pain, fatigue, cramping and other symptoms caused by venous disease. Call us today to schedule an appointment."

During the past decade, Premier Vein and Vascular Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Premier Vein and Vascular Center" are "Crohn Disease" (3 trials), "Diabetic Foot" (1 trials) and "Peripheral Arterial Disease" (1 trials). Many other conditions were trialed in "Premier Vein and Vascular Center" in a lesser frequency.

Most popular intervention types in "Premier Vein and Vascular Center" are "Drug" (3 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ozanimod" (3 trials), "Placebo" (3 trials), "10 x 10^6 cells" (1 trials), "3 x 10^6 cells" (1 trials) and "30 x 10^6 cells" (1 trials). Other intervention names were less common.

The vast majority of trials in "Premier Vein and Vascular Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Premier Vein and Vascular Center". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Premier Vein and Vascular Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Premier Vein and Vascular Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".